Unknown

Dataset Information

Neonatal Outcomes After COVID-19 Vaccination in Pregnancy.


ABSTRACT:

Importance

Better knowledge about neonatal adverse events after COVID-19 vaccination during pregnancy could help address concerns about vaccine safety.

Objective

To evaluate the risks of neonatal adverse events after exposure to COVID-19 vaccination during pregnancy.

Design, setting, and participants

Population-based cohort study including all infants in Sweden and Norway born from June 2021 to January 2023. Unique personal identity numbers were used to link individual information from different national registers.

Exposure

Administration of any mRNA vaccine against COVID-19 during pregnancy, irrespective of previous vaccination, number of doses during pregnancy, or vaccine manufacturer.

Main outcomes and measures

Outcomes were neonatal conditions with b

SUBMITTER: Norman M 

PROVIDER: S-EPMC10848052 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature